Everlywell raises $175 million to broaden virtual care options and scale its at-home health testing
Digital health start-up Everlywell has actually raised a $175 million Series D funding round, following relatively fast on the heels of a $25 million Series C round it closed in February of this year. The Series D consisted of a host of brand-new investors, including BlackRock, The Chernin Group (TCG), Foresite Capital, Greenspring Associates, Morningside Ventures and […] Previously this year, Everlywell released an at-home COVID-19 test collection kit– the first of this type of test to receive an emergency authorization from the U.S. Food and Drug Administration (FDA) for its use that enabled cooperation with multiple lab service companies over time. The COVID-19 test package joins its numerous other offerings, which consist of tests for thyroid hormonal agent levels, food and irritant level of sensitivity, women’s health and fertility, vitamin D deficiency and more. That’s not new for Everlywell, according to Cheek– customers have actually constantly had a high degree of satisfaction with the company’s items. “It’s not simply for Everlywell. …
Recent Comments